“Silent” strokes are more common than overt strokes in older patients undergoing elective non-cardiac surgery, investigators with the NeuroVISION study have found.
The FDA has expanded its indication for TAVR to low-risk patients, the agency announced August 16, approving a handful of valves for an intervention that was previously limited to intermediate- and high-risk patients.
A combination of 107 chest compressions per minute at a depth of 4.7 centimeters is the optimal CCR-CCD (chest compression rate-chest compression depth) ratio for survival after an out-of-hospital cardiac arrest, researchers reported August 14 in JAMA Cardiology.
Mental illnesses including developmental and mood disorders are prevalent in adolescents and adults with CHD, an American Journal of Cardiology study found, suggesting mental health care might be a beneficial factor in comprehensive treatment.
Biopharmaceutical company Renovacor, Inc., on August 14 announced it had raised $11 million in Series A financing to further develop its gene therapy-based treatments for CVD.
Illinois Gov. JB Pritzker signed House Bill 3435 this month, CNN reported—a law that will require insurance companies to cover all costs of EpiPen injections for anyone under 18 years old.
Health officials in the Midwest have confirmed at least 22 cases of vaping-related lung injury this month, according to recent reports, and are in the process of investigating as many as 18 more.
Intensive blood pressure control resulted in fewer white matter brain lesions than standard BP control in a recent study of nearly 450 hypertensive patients, suggesting stricter hypertension management could have significant benefits for brain health.
CMS this month announced that, after continued analysis of Abiomed’s Impella RP system, it will no longer be cutting its reimbursement rate for the heart pump in October.
Long-term exposure to ambient air pollutants—especially ozone—increase a person’s chance of developing emphysema, according to research published August 13 in JAMA.
Compared to on-pump CABG, off-pump surgery is associated with lower rates of revascularization and a significantly increased risk of all-cause death at three years, according to an analysis of the EXCEL trial.
